BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34998158)

  • 1. The CBL-LSD1-CXCL8 axis regulates methionine metabolism in glioma.
    Chang J; Wang L; Zhou X; Yuan J; Xu W
    Cytokine; 2022 Mar; 151():155789. PubMed ID: 34998158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation.
    Anan K; Hino S; Shimizu N; Sakamoto A; Nagaoka K; Takase R; Kohrogi K; Araki H; Hino Y; Usuki S; Oki S; Tanaka H; Nakamura K; Endo F; Nakao M
    Nucleic Acids Res; 2018 Jun; 46(11):5441-5454. PubMed ID: 29618057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.
    Liu J; Feng J; Li L; Lin L; Ji J; Lin C; Liu L; Zhang N; Duan D; Li Z; Huang B; Zhang Y; Lu J
    EMBO Rep; 2020 Feb; 21(2):e48597. PubMed ID: 31833203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
    Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y
    Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development.
    Han X; Gui B; Xiong C; Zhao L; Liang J; Sun L; Yang X; Yu W; Si W; Yan R; Yi X; Zhang D; Li W; Li L; Yang J; Wang Y; Sun YE; Zhang D; Meng A; Shang Y
    Mol Cell; 2014 Aug; 55(3):482-94. PubMed ID: 25018020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch.
    Sun H; Liang L; Li Y; Feng C; Li L; Zhang Y; He S; Pei D; Guo Y; Zheng H
    Sci Rep; 2016 Aug; 6():30903. PubMed ID: 27481483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
    Hino S; Kohrogi K; Nakao M
    Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
    Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
    Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma.
    Kim S; Bolatkan A; Kaneko S; Ikawa N; Asada K; Komatsu M; Hayami S; Ojima H; Abe N; Yamaue H; Hamamoto R
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31805626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    Hosseini A; Minucci S
    Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
    Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.
    Yi L; Cui Y; Xu Q; Jiang Y
    Oncol Rep; 2016 Nov; 36(5):2935-2945. PubMed ID: 27632941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis.
    Lee JY; Park JH; Choi HJ; Won HY; Joo HS; Shin DH; Park MK; Han B; Kim KP; Lee TJ; Croce CM; Kong G
    Oncogene; 2017 Sep; 36(39):5512-5521. PubMed ID: 28534506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
    Tu WJ; McCuaig RD; Tan AHY; Hardy K; Seddiki N; Ali S; Dahlstrom JE; Bean EG; Dunn J; Forwood J; Tsimbalyuk S; Smith K; Yip D; Malik L; Prasanna T; Milburn P; Rao S
    Front Immunol; 2020; 11():1228. PubMed ID: 32612611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
    Zhang C; Hoang N; Leng F; Saxena L; Lee L; Alejo S; Qi D; Khal A; Sun H; Lu F; Zhang H
    J Biol Chem; 2018 Mar; 293(10):3663-3674. PubMed ID: 29358331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SYVN1-MTR4-MAT2A Signaling Axis Regulates Methionine Metabolism in Glioma Cells.
    Wang L; Hu B; Pan K; Chang J; Zhao X; Chen L; Lin H; Wang J; Zhou G; Xu W; Yuan J
    Front Cell Dev Biol; 2021; 9():633259. PubMed ID: 33859984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone demethylase LSD1/KDM1A promotes the DNA damage response.
    Mosammaparast N; Kim H; Laurent B; Zhao Y; Lim HJ; Majid MC; Dango S; Luo Y; Hempel K; Sowa ME; Gygi SP; Steen H; Harper JW; Yankner B; Shi Y
    J Cell Biol; 2013 Nov; 203(3):457-70. PubMed ID: 24217620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.